Pathology and Laboratory Medicine -
Topic: HPV - Associated Oropharyngeal Squamous Cell Carcinoma - The Latest
Monday, May 23, 2022
12:00 PM - 1:00 PM
James Lewis, Jr.,, M.D.
Professor of Microbiology and Immunology, Department of Pathology
Professor of Otolaryngology - Head and Neck Surgery
Vanderbilt University Medical Center
Faculty, Invitation Only, Residents/Fellows
Upon completion of the presentation, participants will be able to:
1) Define and describe the latest in P16 and HPV testing in head and neck carcinomas according to the College of American Pathologists Guidelines.
2) Recognize when (and when not) to test for high risk HPV or its surrogate marker p16, according to anatomic subsite of the primary tumor - oropharynx versus non-oropharynx.
3) Become familiar with alternative specimens, including fine needle aspiration fluid and circulating blood serum or plasma, for evaluation for cell free HPV DNA as a diagnostic test in patients with oropharyngeal squamous cell carcinoma.
The University of Florida College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Florida College of Medicine designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the Activity.
James Lewis, Jr.,, M.D. has disclosed that he/she has no relevant financial disclosures. No one else in a position to control content has any financial relationships to disclose.
For additional information, contact Karen Earick (902) 244-6069 firstname.lastname@example.org.